| Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Income (Loss) Per Share |
The
schedule of potentially dilutive securities excluded from the calculation of diluted net loss per share is included below:
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Income (Loss) Per Share
| | |
Three
and Six Months Ended
June 30, | |
| | |
2026 | | |
2025 | |
| Options to purchase Common Stock | |
| 3,324 | | |
| 3,372 | |
| Warrants to purchase Common Stock | |
| 258,252,037 | | |
| 258,254,405 | |
| Series E-1 Shares | |
| 184,169,905 | | |
| 149,350,650 | |
| Series F-1 Shares | |
| 1,706,493,507 | | |
| 1,706,493,507 | |
| Series G-1 Shares | |
| 103,383,799 | | |
| - | |
| Purchase rights to purchase Common Stock | |
| 1,505,819,328 | | |
| 1,513,848,899 | |
| Convertible debt | |
| 3,094,480,358 | | |
| 2,969,614,658 | |
| Total(1) | |
| 6,852,602,258 | | |
| 6,597,565,491 | |
| (1) |
The
potentially dilutive securities in the table above include all potentially dilutive securities that are not included in the diluted
net loss per share as per U.S. GAAP, whereas the total Common Stock reserved for future issuance in Note 8 – Convertible and Redeemable Preferred Stock and Stockholders’ Deficit includes the shares that must legally be reserved based on the applicable
instruments’ agreements. |
|